Inactive Instrument
Bioasis Technologies Inc. Stock Toronto S.E.
Stocks
BTI.H
CA09064N1033
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 1.56M 1.11M 968K 893K 821K 107M 1.58M 10.66M 4.18M 52.09M 4.16M 4.07M 180M | P/E 2021 |
37.2x | P/E 2022 | -6.45x |
|---|---|---|---|---|---|
| Enterprise Value | 1.73M 1.23M 1.07M 991K 911K 118M 1.76M 11.84M 4.64M 57.81M 4.62M 4.52M 199M | EV / Sales 2021 |
6.07x | EV / Sales 2022 | 516x |
| Free-Float |
97.95% | Yield 2021 * |
-
| Yield 2022 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Deborah Rathjen
CEO | Chief Executive Officer | - | 2019-03-10 |
Dave Jenkins
DFI | Director of Finance/CFO | - | 2021-06-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 7.94K | |
| -0.17% | +1.47% | +3.16% | +7.43% | 50.35B | |
| -0.04% | -2.58% | +388.96% | +594.76% | 39.32B | |
| +0.03% | +1.87% | +31.66% | -6.22% | 34.69B | |
| +1.25% | +3.19% | +15.50% | +57.41% | 34.08B | |
| +1.68% | -1.40% | +4.23% | +27.34% | 26.63B | |
| +0.70% | -3.45% | - | - | 16.49B | |
| -0.91% | -0.07% | +70.00% | +114.92% | 15.31B | |
| +0.43% | +3.34% | +14.96% | +17.98% | 13.8B | |
| +0.73% | +2.08% | +16.03% | -31.07% | 12.87B | |
| Average | +0.33% | -0.41% | +68.06% | +97.82% | 27.06B | |
| Weighted average by Cap. | +0.33% | -0.32% | +82.27% | +122.61% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 4.08M 2.9M 2.54M 2.34M 2.15M 279M 4.15M 27.95M 10.97M 137M 10.9M 10.66M 471M | 37.72K 26.85K 23.48K 21.66K 19.91K 2.58M 38.37K 259K 101K 1.26M 101K 98.64K 4.35M |
| Net income | 698K 497K 435K 401K 369K 47.84M 710K 4.79M 1.88M 23.38M 1.87M 1.83M 80.59M | -2.96M -2.11M -1.84M -1.7M -1.56M -203M -3.01M -20.29M -7.96M -99.1M -7.91M -7.74M -342M |
| Net Debt | -2.62M -1.87M -1.63M -1.51M -1.38M -180M -2.67M -17.98M -7.05M -87.82M -7.01M -6.86M -303M | 171K 122K 106K 98.17K 90.25K 11.71M 174K 1.17M 460K 5.72M 457K 447K 19.73M |
Employees
-
Choose MarketScreener 
